These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 36819775)

  • 1. Gene therapy for selected neuromuscular and trinucleotide repeat disorders - An insight to subsume South Asia for multicenter clinical trials.
    Wijekoon N; Gonawala L; Ratnayake P; Sirisena D; Gunasekara H; Dissanayake A; Senanayake S; Keshavaraj A; Hathout Y; Steinbusch HWM; Mohan C; Dalal A; Hoffman E; D de Silva KR
    IBRO Neurosci Rep; 2023 Jun; 14():146-153. PubMed ID: 36819775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Title-molecular diagnostics of dystrophinopathies in Sri Lanka towards phenotype predictions: an insight from a South Asian resource limited setting.
    Wijekoon N; Gonawala L; Ratnayake P; Liyanage R; Amaratunga D; Hathout Y; Steinbusch HWM; Dalal A; Hoffman EP; de Silva KRD
    Eur J Med Res; 2024 Jan; 29(1):37. PubMed ID: 38195599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplex Ligation-Dependent Probe Amplification in X-linked Recessive Muscular Dystrophy in Korean Subjects.
    Suh MR; Lee KA; Kim EY; Jung J; Choi WA; Kang SW
    Yonsei Med J; 2017 May; 58(3):613-618. PubMed ID: 28332368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of 1051 Chinese families with Duchenne/Becker Muscular Dystrophy.
    Kong X; Zhong X; Liu L; Cui S; Yang Y; Kong L
    BMC Med Genet; 2019 Aug; 20(1):139. PubMed ID: 31412794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duchenne Muscular Dystrophy and Becker Muscular Dystrophy Confirmed by Multiplex Ligation-Dependent Probe Amplification: Genotype-Phenotype Correlation in a Large Cohort.
    Vengalil S; Preethish-Kumar V; Polavarapu K; Mahadevappa M; Sekar D; Purushottam M; Thomas PT; Nashi S; Nalini A
    J Clin Neurol; 2017 Jan; 13(1):91-97. PubMed ID: 28079318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of a Multiplex Ligation-Dependent Probe Amplification-Based Next-Generation Sequencing Approach for the Detection of Pathogenesis of Duchenne Muscular Dystrophy and Spinal Muscular Atrophy Caused by Copy Number Aberrations.
    Yang Y; Xia C; Song X; Tang X; Nie X; Xu W; Du C; Zhang H; Luo P
    Mol Neurobiol; 2024 Jan; 61(1):200-211. PubMed ID: 37596438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Analysis-Based Genetic Characterization of a Cohort of Patients with Duchenne and Becker Muscular Dystrophy in Eastern China.
    Zhao HH; Sun XP; Shi MC; Yi YX; Cheng H; Wang XX; Xu QC; Ma HM; Wu HQ; Jin QW; Niu Q
    Chin Med J (Engl); 2018 Apr; 131(7):770-775. PubMed ID: 29578119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of multiplex ligation-dependent probe amplification (MLPA) for Duchenne muscular dystrophy (DMD) gene mutation analysis.
    Murugan S; Chandramohan A; Lakshmi BR
    Indian J Med Res; 2010 Sep; 132():303-11. PubMed ID: 20847377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Report: Whole-Exome Sequencing With MLPA Revealed Variants in Two Genes in a Patient With Combined Manifestations of Spinal Muscular Atrophy and Duchenne Muscular Dystrophy.
    Xia Y; Feng Y; Xu L; Chen X; Gao F; Mao S
    Front Genet; 2021; 12():605611. PubMed ID: 33777091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parental attitudes toward newborn screening for Duchenne/Becker muscular dystrophy and spinal muscular atrophy.
    Wood MF; Hughes SC; Hache LP; Naylor EW; Abdel-Hamid HZ; Barmada MM; Dobrowolski SF; Stickler DE; Clemens PR
    Muscle Nerve; 2014 Jun; 49(6):822-8. PubMed ID: 24307279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic analysis and prenatal diagnosis of Duchenne or Becker muscular dystrophy].
    Zhao W; Jiang N; Li S; Li JS; Miao Y; Liang SY; Yu DY
    Zhonghua Fu Chan Ke Za Zhi; 2019 Apr; 54(4):226-231. PubMed ID: 31006187
    [No Abstract]   [Full Text] [Related]  

  • 12. Overview of gene therapy in spinal muscular atrophy and Duchenne muscular dystrophy.
    Abreu NJ; Waldrop MA
    Pediatr Pulmonol; 2021 Apr; 56(4):710-720. PubMed ID: 32886442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy.
    Ke Q; Zhao ZY; Mendell JR; Baker M; Wiley V; Kwon JM; Alfano LN; Connolly AM; Jay C; Polari H; Ciafaloni E; Qi M; Griggs RC; Gatheridge MA
    World J Pediatr; 2019 Jun; 15(3):219-225. PubMed ID: 30904991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of MLPA in mutation analysis and carrier detection for Duchenne muscular dystrophy.
    Verma PK; Dalal A; Mittal B; Phadke SR
    Indian J Hum Genet; 2012 Jan; 18(1):91-4. PubMed ID: 22754229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoring Protein Expression in Neuromuscular Conditions: A Review Assessing the Current State of Exon Skipping/Inclusion and Gene Therapies for Duchenne Muscular Dystrophy and Spinal Muscular Atrophy.
    Sheikh O; Yokota T
    BioDrugs; 2021 Jul; 35(4):389-399. PubMed ID: 34097287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of dystrophin gene in Iranian Duchenne and Becker muscular dystrophies patients and identification of a novel mutation.
    Zamani GR; Karami F; Mehdizadeh M; Movafagh A; Nilipour Y; Zamani M
    Neurol Sci; 2015 Nov; 36(11):2011-7. PubMed ID: 26081009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A predictive analysis of the association between clinical phenotypes and genotypes in children with Becker muscular dystrophy/Duchenne muscular dystrophy].
    Niu HH; Tao DY; Cheng SQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jun; 22(6):602-607. PubMed ID: 32571459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic diagnosis of Duchenne/Becker muscular dystrophy by MLPA].
    Zhang Y; Liu X; He R; Ma H; Zhao Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Jun; 31(3):338-43. PubMed ID: 24928015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and emerging therapies for Duchenne muscular dystrophy and spinal muscular atrophy.
    Iftikhar M; Frey J; Shohan MJ; Malek S; Mousa SA
    Pharmacol Ther; 2021 Apr; 220():107719. PubMed ID: 33130193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mutation screening of 433 families with Duchenne/Becker muscular dystrophy].
    Bai Y; Li S; Zong YN; Li XL; Zhao ZH; Kong XD
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(16):1261-9. PubMed ID: 27122458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.